MERSANA THERAPEUTICS
2.2800
29-十一月-24 12:45:00
15 分钟延时
股票
+0.0900
+4.11%
今日范围
2.1550 - 2.3100
ISIN
N/A
来源
NASDAQ
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 8月 2023 15:05:52 条件 Nasdaq GlobeNewswire
-
27 7月 2023 06:06:23 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 7月 2023 15:05:00 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials
15 6月 2023 06:30:00 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 6月 2023 15:05:00 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
24 5月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
09 5月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 5月 2023 15:05:01 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Bank of America Securities 2023 Healthcare Conference
03 5月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host First Quarter 2023 Conference Call on May 9, 2023
02 5月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Upcoming Presentations at 2023 ASCO Annual Meeting
26 4月 2023 15:05:01 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 4月 2023 15:05:00 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Clinical Hold on XMT-2056 Phase 1 Clinical Trial
13 3月 2023 06:30:00 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Statement About SVB
10 3月 2023 18:10:38 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 3月 2023 15:05:00 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host Fourth Quarter and Year End 2022 Conference Call on February 28, 2023
21 2月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 2月 2023 15:05:00 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
02 2月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
01 2月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Initiation of Phase 1 Trial of XMT-2056 in HER2-Expressing Tumors
25 1月 2023 07:00:01 条件 Nasdaq GlobeNewswire